Ability Biologics

Healthcare & Life Sciences

Recent Finacing

Seed

Recent Raise

$12M

Ability Biologics is a biotech startup focused on creating next-generation antibody therapeutics for unmet medical needs using their proprietary AI platform, AbiLeap™.

Total Funding

$12M

Headquarters

Montreal, Canada

Founded

N/A

Website

ability.bio

Focus Areas

Antibody Therapeutics

Preclinical Development

AI Platform

Drug Candidates

Biotechnology

Proprietary Technology

Investors